Amylase 20000 UNT / lipase 5000 UNT / protease 20000 UNT Delayed Release Oral Capsule [Cotazym]
RxNorm 809248
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 809248 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: amylase 20000 UNT / lipase 5000 UNT / protease 20000 UNT Delayed Release Oral Capsule [Cotazym].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 20000 UNT / lipase 5000 UNT / protease 20000 UNT Delayed Release Oral Capsule [Cotazym]
(Atom ID: 12361209)
SY
Synonym (SY):
Cotazym-S (amylase 20,000 UNT / lipase 5000 UNT/ protease 20,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845246)
SY